A carregar...
Biomarkers for immunotherapy in bladder cancer: a moving target
Treatment options for metastatic urothelial carcinoma (mUC) remained relative unchanged over the last 30 years with combination chemotherapy as the mainstay of treatment. Within the last year the landscape for mUC has seismically shifted following the approval of five therapies targeting the program...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697433/ https://ncbi.nlm.nih.gov/pubmed/29157296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0299-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|